The Escherichia coli R factor-derived chloramphenicol resistance (camr) nificant that the expression of the camr gene in yeast results in the acquisition by transformed cells of an easily detectable phenotype-namely, resistance to chloramphenicol. The possible use of the latter observation for the investigation of the mechanisms of transcription, RNA processing, and translation in eukaryotes will be discussed.
The eukaryotic microorganism Saccharomyces cerevisiae appears to occupy an intermediate position between prokaryotes and higher eukaryotes in the processing of nuclear transcripts. In prokaryotes, transcription and translation are closely coupled; in all eukaryotes, the nuclear transcripts are initially generated and primarily modified in the nucleus before being transported to the cytoplasm where they are subsequently translated. In S. cerevisiae, as in other eukaryotes, modification of mRNA involves posttranscriptional capping and poly(A) addition at their 5' and 3' ends, respectively; however, in contrast to higher eukaryotes, splicing of the mRNA has not yet been demonstrated. In the most extensively studied case in yeast there is a strict colinearity between the nucleotide and amino acid sequences of the iso-1-cytochrome c gene and the protein for which it codes (1) .
The advent of recombinant DNA technology and the development of a procedure for the transformation of yeast (2) makes it possible to investigate the behavior and expression of genes in heterologous cellular environments. Although several laboratories have reported that eukaryotic genes can be transcribed (3, 4) and in some cases translated and expressed (5) (6) (7) (8) in Escherichza coli, there are no published reports of prokaryotic genes being expressed in yeast. The present paper describes experiments which demonstrate that the bacterial plasmid gene camr, which specifies resistance to chloramphenicol in E. coli (9) , is Assay of Chloramphenicol Acetyltransferase. Cell-free extracts from E. coli strain RR 101 harboring pBR325 were prepared by suspending the cells in 100 mM Tris-HCl at pH 7.8 and sonicating the suspension three times for 15 sec each time. The supernatant resulting from centrifugation at 27,000 X g for 30 min was used for enzyme assays. Yeast cell-free extracts were prepared from 7-ml cultures grown in appropriately supplemented YNBD medium. The cells in early stationary phase (z108 cells per ml) were harvested by centrifugation, washed with water, suspended in 0.4 ml of 100 mM Tris-HCl at pH 7.8, and homogenized in the presence of glass beads for 2 min in a Braun homogenizer. After centrifugation at 7800 X g, the supernatant was used for enzyme assays. The enzyme reaction mixture (total volume, 0.25 ml) contained 23 Yeast Genetic Techniques. The techniques and media have been described (12) .
RESULTS

Description of the Recombinant Plasmids Used in This
Work. Plasmid pYTI 1-LEU2 is a composite vector consisting of the bacterial plasmid pBR325 (13), the yeast 2-nm DNA plasmid (14) , and a fragment of DNA containing the yeast LEU2 structural gene derived from plasmid pYeleulO (6) (Fig.   1 ). The entire 2-Aum DNA was ligated to pBR325 at the Pst I restriction site within the ampicillin-resistance (ampr) gene. An Xho I/Sal I restriction fragment of plasmid pYeleulO, containing the yeast LEU2 gene, was ligated at the Sal I cleavage site of the pBR325-2 ,um DNA chimera, within the tetracycline-resistance (tet') gene. The resulting composite vector has the genotype cam7 amps tets. Plasmid pYelS was constructed and kindly made available to us by J. Hicks, J. Broach, J. Strathern, and A. Klar. It is a composite of pBR322 (15) and 2A are resistant to up to 2 mg of chloramphenicol per ml, but both are sensitive on medium containing 3 mg/ml. The Leu+ transformants of AH22 used in this cross are resistant to 3 mg/ml chloramphenicol. Spore clones from complete tetrads were tested by replica plating on YNBD plus histidine and on YEPGE plus chloramphenicol at 3 mg/ml. The plates were scored after 4-6 days' incubation at 30'C.
between the determinants for the Leu+ and CAMR phenotypes.
Yeast Cells Transformed with Plasmid pYT11-LEU2 Contain Chloramphenicol Acetyltransferase Activity. In E. coli, the plasmid cam7 gene codes for a detoxification enzyme, chloramphenicol acetyltransferase (10) . The enzyme inactivates the antibiotic via the following reactions: chloramphenicol + acetyl-CoA -3-acetylchloramphenicol + acetyl-CoA -1,3-acetylchloramphenicol. Both the mono-and diacetylated derivatives of the drug are inactive and can be readily identified by thin-layer chromatography (10) . Cell-free extracts of strain 21D transformed with pYT11-LEU2 were assayed for chloramphenicol acetyltransferase activity, along with appropriate controls. The presence of monoacetylated chloramphenicol among the reaction products (Fig. 4) demonstrates that the extracts contained chloramphenicol acetyltransferase activity. In contrast, extracts from cells transformed with plasmid pYe13 did not exhibit this enzymatic activity. The activity was thermolabile and dependent on acetyl-CoA (data not shown). The kinetics of accumulation of acetylated chloramphenicol was linear for up to 40 min (Fig. 5) .
To further verify that monoacetylchloramphenicol was a reaction product [acetyl-3H]acetyl-CoA,(1.5 nmol; 1.3 Ci/ mmol; New England Nuclear) was added in addition to nonlabeled acetyl-CoA in the reaction mixture (see Materials and Methods). The reaction products were analyzed by thin-layer chromatography, and the spot corresponding to monoacetylchloramphenicol was cut out and assayed for radioactivity. From the ratio of 3H to 14C, it was determined that the molar ratio of acetyl groups to chloramphenicol was 0.97:1. A similar value (0.95:1) was obtained when the E. coli extract was substituted in the reaction. It was concluded that the yeast extract catalyzes the formation of monoacetylated chloramphenicol, as does the bacterial extract, by the transfer of the acetyl group from acetyl-CoA to chloramphenicol. Fig. 6 illustrates the fact that, in the meiotic progeny of appropriate crosses, chloramphenicol acetyltransferase activity cosegregated with the Leu+ CAMR phenotype.
DISCUSSION
The data presented in this paper demonstrate that the E. coli plasmid gene cam7 is functionally expressed in yeast cells. Yeast cells harboring plasmid pYT11-LEU2, carrying the camr gene, display the following characteristics: (i) resistance to chlbramphenicol at a level sufficiently higher than that of control (19) and will be useful in this respect. Also, the chloramphenicol acetyltransferase protein can be easily purified by a single-step affinity-chromatography column (10) and is therefore readily available for physical and enzymatic characterization as well as for the production of antiserum. In addition, most of the amino acid sequence of the protein has been determined (20, 21) and should provide a useful reference for comparative studies. Finally, it is possible to obtain, in yeast, mutants in which some aspect of either the expression of the cam r gene or the maintenance or replication of the plasrnid is altered. By selecting for growth on high levels of chloramphenicol, a number of mutants have already been isolated in which acetyltransferase activity is increased 20-to 40fold over the levels observed in the primary "wild type" transformants. The investigation of the mutational event(s) leading to such variants might prove useful in increasing our understanding of the mechanisms of transcription, mRNA processing, and translation in eukaryotes.
